FDA COVID-19 Update

FDA has authorized 141 tests under EUAs; these include 120 molecular tests, 20 antibody tests, and 1 antigen test.

By: Contract Pharma

Contract Pharma Staff

The FDA has taken the following actions as of June 18 in the ongoing response to the COVID-19 pandemic: The FDA participated in the International Society for Neglected Tropical Diseases virtual meeting to discuss how the CURE ID app can be used to capture case reports regarding treatments and advance research into neglected tropical disease and COVID-19. Visit the FDA’s new web section Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices. This ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters